SCHEMBL22071063

SCHEMBL22071063

O=C(O)/C=C/c1ccc(/C=C/C(=O)OCc2ccccc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.84
▸ AKR1B10 O60218 7/20 0.82
▸ AKR1B1 P15121 7/20 0.82
▸ CA12 O43570 4/20 0.82
▸ CA7 P43166 4/20 0.82
▸ CA9 Q16790 4/20 0.82
▸ CA14 Q9ULX7 4/20 0.82
▸ CA4 P22748 3/20 0.82
▸ CA6 P23280 3/20 0.82
▸ CA5A P35218 3/20 0.82
▸ CA5B Q9Y2D0 3/20 0.82
▸ HCAR2 Q8TDS4 6/20 0.73
▸ TTR P02766 1/20 0.69
▸ MAOB P27338 1/20 0.62
▸ HDAC3 O15379 1/20 0.56
▸ TNKS O95271 1/20 0.56
▸ HDAC4 P56524 1/20 0.56
▸ HDAC1 Q13547 1/20 0.56
▸ HDAC7 Q8WUI4 1/20 0.56
▸ HDAC2 Q92769 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Cinnamate SCHEMBL30513717 0.97 LMNA (0.90) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL13552179 0.95 LMNA (0.93) LMNAAKR1B10AKR1B1CA12CA7
Benzyl Cinnamate SCHEMBL43213 0.92 LMNA (1.00) LMNAAKR1B10AKR1B1CA12CA7
Benzyl Cinnamate SCHEMBL1871854 0.92 LMNA (1.00) LMNAAKR1B10AKR1B1CA12CA7
Benzyl Cinnamate SCHEMBL43212 0.92 LMNA (1.00) LMNAAKR1B10AKR1B1CA12CA7
Benzyl Cinnamate SCHEMBL901152 0.92 LMNA (1.00) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL4501587 0.90 AKR1B10 (1.00) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL4501585 0.90 AKR1B10 (1.00) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL15419990 0.90 AKR1B10 (1.00) LMNAAKR1B10AKR1B1CA12CA7
SCHEMBL18964940 0.89 LMNA (0.77) LMNAAKR1B10AKR1B1CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365192-B2 Pyridine compound substituted with azole TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-06-21 — — US disclosed
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE TAISHO PHARMACEUTICAL CO., LTD (JP) 2021-04-29 — — US disclosed
EP-3666766-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE Taisho Pharmaceutical Co., Ltd. (JP) 2020-06-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE CYP2C19, CYP4A11, CYP11B1 LMNA 4665/4885AKR1B10 84/4885AKR1B1 85/4885
US-11365192-B2 Pyridine compound substituted with azole CYP2C19, CYP4A11, CYP11B1 LMNA 4665/4885AKR1B10 84/4885AKR1B1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback